Psychedelic Therapy in New York City: Ketamine, Legal Options, and What’s Next

Last Updated: May 2026

Where New York Currently Stands

New York City is one of the most active markets for ketamine therapy in the country, with dozens of licensed clinics operating in Manhattan, Brooklyn, Queens, and beyond. Ketamine is FDA-cleared in its nasal spray form (Spravato) for treatment-resistant depression and is also used off-label as an IV infusion for depression, anxiety, PTSD, and chronic pain. This is not a legal gray area. Ketamine therapy in New York is medically supervised, clinically established, and accessible right now.

Psilocybin is a different story. As of May 2026, psilocybin remains a Schedule I controlled substance under both New York state law and federal law. Possession and use carry criminal penalties. No licensed psilocybin therapy program currently exists in New York State, and no municipality including New York City has passed a formal decriminalization resolution for it. If you have read otherwise online, treat that information with caution and verify it before acting on it.

This does not mean nothing is happening. It means the legal framework has not caught up yet with where the clinical research is pointing.

Ketamine Therapy NYC: What Legal Access Looks Like Right Now

Ketamine therapy is the most practical entry point into psychedelic therapy in New York City today. It is also among the better-studied options available. A growing body of research supports its use for treatment-resistant depression, and Spravato (esketamine nasal spray) carries full FDA approval for that indication, which means it is often covered by major insurance plans when eligibility criteria are met.

IV ketamine infusions are a separate category. They remain off-label for psychiatric conditions, which means most insurance plans will not cover them. A single IV session at a NYC clinic typically costs between $500 and $900, with the higher end of that range reflecting both the cost of operating in one of the world’s most expensive cities and the clinical oversight involved. A full induction series of six to eight sessions can bring the total to several thousand dollars, so it is worth asking clinics upfront what is included in their pricing and what is billed separately.

Quality matters enormously in this space. NYC has reputable, well-staffed ketamine clinics run by experienced psychiatrists and anesthesiologists, and it also has providers offering discounted sessions with less clinical depth. When you are considering ketamine therapy in New York City, the right questions are not only about price: ask about the psychiatric evaluation process, how they handle adverse reactions, and whether integration support is included or available as an add-on.

For context on how ketamine fits within the broader legal picture nationwide, see our overview: Is Psychedelic Therapy Legal in the United States?

Psilocybin Therapy in New York: The Legislative Horizon

While psilocybin therapy is not legal in New York today, the legislative momentum is real and worth following closely. In the current 2025-2026 session, several bills are in play. Senate Bill S495, introduced by Senator Nathalia Fernandez, proposes a licensed facilitator model for psilocybin-assisted therapy and would establish a grant fund for veterans, first responders, and low-income patients. Its companion Assembly Bill A3775 covers similar ground. A separate Assembly Bill, A628, takes a broader decriminalization approach, targeting the removal of criminal penalties for adult possession of psilocybin and several other plant- and fungus-based substances.

As of this writing, S495 has been referred to the Senate Finance Committee twice, most recently in January 2026, without advancing to a vote. That reflects the current political reality: there is genuine legislative interest in psilocybin therapy in New York, but no clear timeline for passage. Advocates working in this space describe the realistic window as one to three years, contingent on political momentum and the accumulating weight of clinical evidence.

The clinical evidence itself continues to build. Psilocybin has received Breakthrough Therapy designation from the FDA for major depressive disorder and treatment-resistant depression, which is a meaningful signal even if it does not guarantee a specific regulatory outcome. Research institutions in New York State are conducting and enrolling participants in clinical trials, which represents a legal pathway for some individuals who qualify.

If you want to explore whether you qualify for an active psilocybin clinical trial in New York, ClinicalTrials.gov is the place to check. That is a legitimate, supervised route that exists right now, and it is worth knowing about.

What About Oregon and Colorado?

Oregon and Colorado have each built state-level licensed psilocybin programs that are operational. Traveling to either state to participate in a licensed psilocybin session is legal, as long as you stay within the regulatory framework those states have established. Bringing any product back to New York is not legal, and that distinction matters. If you are considering traveling for psilocybin therapy, the preparation and integration work you do before and after the experience is as important as the session itself, and doing it with professional support significantly affects outcomes.

The Role of a Concierge Guidance Service in This Landscape

One of the more consistent challenges New Yorkers face when exploring psychedelic therapy is not finding information. There is no shortage of that. The challenge is sorting through it accurately, understanding which options actually apply to your situation, and navigating the gap between what is theoretically available and what you can realistically access in a safe, well-supported way.

This is where concierge-style guidance makes a practical difference. Rather than working through the options alone and potentially making decisions based on outdated or incomplete information, you work with someone who can assess your specific situation, explain the legal landscape clearly, and help you identify which pathways are genuinely available to you right now, whether that is ketamine therapy in New York City, a clinical trial, or a properly supported experience in Oregon or Colorado.

JourneyŌM does exactly this. We are not a clinic, and we are not selling sessions. We are a safety and continuity-of-care layer that helps seekers move through this space with accurate information and professional support at every stage.

What to Do Right Now

If you are a New Yorker looking at psychedelic therapy and trying to figure out where to start, the most useful first step is a direct conversation with someone who understands the current landscape. That means getting clear on your goals, your mental health history, what the available options actually are for someone in your situation, and what preparation and integration support should look like.

Ketamine therapy in New York City is accessible today and may be the right starting point depending on your circumstances. Psilocybin therapy in New York may be coming, but it is not here yet, and building a plan around legislation that has not passed is not a sound approach. If psilocybin is where you are pointing, there are legal, well-supported ways to explore that now through clinical trials or guided travel, and doing that with professional guidance makes a meaningful difference.

Start with a free 15-minute call or a full concierge consultation using the links below. We can help you understand exactly where things stand and what makes sense for you.